Tevogen.AI expands Microsoft, Databricks ties for cancer model beta

Go back to Tevogen.AI expands Microsoft, Databricks ties for cancer model beta

Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcellâ„¢ Model With a Focus on Oncology

August 5, 2025 2:32 PM UTC

Tevogen.AI to explore external market opportunities as a potential revenue source. Beta version to incorporate oncology targets, enhancing the accuracy and diversity of the PredicTcell model and potentially accelerating cancer immunotherapy development.Tevogen.AI to develop enhanced analytics and visualization tools, for the PredicTcell model to support its internal R&D teams.

WARREN, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) --... More